Page last updated: 2024-10-31

methoxyphenamine and Pulmonary Disease, Chronic Obstructive

methoxyphenamine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

methoxyphenamine: structure
methoxyphenamine : An amphetamine methylated on nitrogen and with the phenyl ring methoxylated at C-2. A beta-adrenergic receptor agonist, it is used as a bronchodilator.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
" Treatment groups received different dosage of MC (3, 9, and 27 mg daily, MC group) or prednisone (0."1.32Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease. ( Bai, CX; Chen, J; Hong, QY; Wang, YH, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, YH1
Bai, CX1
Hong, QY1
Chen, J1

Other Studies

1 other study available for methoxyphenamine and Pulmonary Disease, Chronic Obstructive

ArticleYear
Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease.
    Acta pharmacologica Sinica, 2003, Volume: 24, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Interleukin-1; Interleukin-6; Leuko

2003